109 related articles for article (PubMed ID: 9200124)
1. Identification of hemoglobin degradation products in Plasmodium falciparum.
Kamchonwongpaisan S; Samoff E; Meshnick SR
Mol Biochem Parasitol; 1997 Jun; 86(2):179-86. PubMed ID: 9200124
[TBL] [Abstract][Full Text] [Related]
2. Cysteine proteinase inhibitors block early steps in hemoglobin degradation by cultured malaria parasites.
Gamboa de Domínguez ND; Rosenthal PJ
Blood; 1996 May; 87(10):4448-54. PubMed ID: 8639807
[TBL] [Abstract][Full Text] [Related]
3. Plasmodium falciparum: effects of proteinase inhibitors on globin hydrolysis by cultured malaria parasites.
Rosenthal PJ
Exp Parasitol; 1995 Mar; 80(2):272-81. PubMed ID: 7895837
[TBL] [Abstract][Full Text] [Related]
4. A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum.
Rosenthal PJ; McKerrow JH; Aikawa M; Nagasawa H; Leech JH
J Clin Invest; 1988 Nov; 82(5):1560-6. PubMed ID: 3053784
[TBL] [Abstract][Full Text] [Related]
5. Purification of human erythrocyte proteolytic enzyme responsible for degradation of oxidant-damaged hemoglobin. Evidence for identifying as a member of the multicatalytic proteinase family.
Sacchetta P; Battista P; Santarone S; Di Cola D
Biochim Biophys Acta; 1990 Mar; 1037(3):337-43. PubMed ID: 2178687
[TBL] [Abstract][Full Text] [Related]
6. Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway.
Gluzman IY; Francis SE; Oksman A; Smith CE; Duffin KL; Goldberg DE
J Clin Invest; 1994 Apr; 93(4):1602-8. PubMed ID: 8163662
[TBL] [Abstract][Full Text] [Related]
7. The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif.
Pandey KC; Wang SX; Sijwali PS; Lau AL; McKerrow JH; Rosenthal PJ
Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9138-43. PubMed ID: 15964982
[TBL] [Abstract][Full Text] [Related]
8. Stage-specific antimalarial activity of cysteine protease inhibitors.
Shenai BR; Semenov AV; Rosenthal PJ
Biol Chem; 2002 May; 383(5):843-7. PubMed ID: 12108550
[TBL] [Abstract][Full Text] [Related]
9. Characterization of native falcipain, an enzyme involved in Plasmodium falciparum hemoglobin degradation.
Francis SE; Gluzman IY; Oksman A; Banerjee D; Goldberg DE
Mol Biochem Parasitol; 1996 Dec; 83(2):189-200. PubMed ID: 9027752
[TBL] [Abstract][Full Text] [Related]
10. The Plasmodium circumsporozoite protein is proteolytically processed during cell invasion.
Coppi A; Pinzon-Ortiz C; Hutter C; Sinnis P
J Exp Med; 2005 Jan; 201(1):27-33. PubMed ID: 15630135
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the autophagy marker protein Atg8 reveals atypical features of autophagy in Plasmodium falciparum.
Navale R; Atul ; Allanki AD; Sijwali PS
PLoS One; 2014; 9(11):e113220. PubMed ID: 25426852
[TBL] [Abstract][Full Text] [Related]
12. Localization and characterization of hemoglobin-degrading aspartic proteinases from the malarial parasite Plasmodium falciparum.
vander Jagt DL; Hunsaker LA; Campos NM; Scaletti JV
Biochim Biophys Acta; 1992 Aug; 1122(3):256-64. PubMed ID: 1504087
[TBL] [Abstract][Full Text] [Related]
13. Generation of hemoglobin peptides in the acidic digestive vacuole of Plasmodium falciparum implicates peptide transport in amino acid production.
Kolakovich KA; Gluzman IY; Duffin KL; Goldberg DE
Mol Biochem Parasitol; 1997 Aug; 87(2):123-35. PubMed ID: 9247924
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of a hemoglobin degrading aspartic protease from the malarial parasite Plasmodium vivax.
Sharma A; Eapen A; Subbarao SK
J Biochem; 2005 Jul; 138(1):71-8. PubMed ID: 16046450
[TBL] [Abstract][Full Text] [Related]
15. Plasmodium falciparum: isolation and characterization of a 55-kDa protease with a cathepsin D-like activity from P. falciparum.
Bailly E; Savel J; Mahouy G; Jaureguiberry G
Exp Parasitol; 1991 Apr; 72(3):278-84. PubMed ID: 2015866
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Plasmodium falciparum oocyst production by membrane-permeant cysteine protease inhibitor E64d.
Eksi S; Czesny B; van Gemert GJ; Sauerwein RW; Eling W; Williamson KC
Antimicrob Agents Chemother; 2007 Mar; 51(3):1064-70. PubMed ID: 17178799
[TBL] [Abstract][Full Text] [Related]
17. Analysis of antimalarial synergy between bestatin and endoprotease inhibitors using statistical response-surface modelling.
Gavigan CS; Machado SG; Dalton JP; Bell A
Antimicrob Agents Chemother; 2001 Nov; 45(11):3175-81. PubMed ID: 11600374
[TBL] [Abstract][Full Text] [Related]
18. Identifying Plasmodium falciparum cytoadherence-linked asexual protein 3 (CLAG 3) sequences that specifically bind to C32 cells and erythrocytes.
Ocampo M; Rodríguez LE; Curtidor H; Puentes A; Vera R; Valbuena JJ; López R; García JE; Ramírez LE; Torres E; Cortes J; Tovar D; López Y; Patarroyo MA; Patarroyo ME
Protein Sci; 2005 Feb; 14(2):504-13. PubMed ID: 15659379
[TBL] [Abstract][Full Text] [Related]
19. Identification of three stage-specific proteinases of Plasmodium falciparum.
Rosenthal PJ; Kim K; McKerrow JH; Leech JH
J Exp Med; 1987 Sep; 166(3):816-21. PubMed ID: 3305763
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium falciparum: inhibitors of lysosomal cysteine proteinases inhibit a trophozoite proteinase and block parasite development.
Rosenthal PJ; McKerrow JH; Rasnick D; Leech JH
Mol Biochem Parasitol; 1989 Jun; 35(2):177-83. PubMed ID: 2671722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
